Radiomics signature extracted from diffusion-weighted magnetic resonance imaging predicts outcomes in osteosarcoma
Authors:
Open Access
- 1 December 2019
- journal article
- research article
- Published by Elsevier in Journal of Bone Oncology
- Vol. 19, 100263
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Project of China (2017YFC0113202)
This publication has 40 references indexed in Scilit:
- Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?Insights into Imaging, 2012
- Radiomics: Extracting more information from medical images using advanced feature analysisEuropean Journal of Cancer, 2012
- Emerging drugs for high-grade osteosarcomaExpert Opinion on Emerging Drugs, 2010
- Estimated cumulative radiation dose from PET/CT in children with malignancies: a 5-year retrospective reviewPediatric Radiology, 2009
- Improvement in Histologic Response But Not Survival in Osteosarcoma Patients Treated With Intensified Chemotherapy: A Randomized Phase III Trial of the European Osteosarcoma IntergroupJNCI: Journal of the National Cancer Institute, 2007
- Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapyCancer, 2006
- Concordance probability and discriminatory power in proportional hazards regressionBiometrika, 2005
- Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression dataBioinformatics, 2005
- X-TileClinical Cancer Research, 2004
- A Class of Weighted Log-Rank Tests for Survival Data When the Event is RareJournal of the American Statistical Association, 2000